Doubt cast on MS cannabis treatment

 

There is no strong evidence to back the use of cannabis extract in the treatment of multiple sclerosis (MS), it was claimed.

A review of evidence on the first licensed preparation, Sativex, said there were "limitations" which made it difficult to identify the place of the product in clinical practice.

However the makers of the drug said they believed the comments gave a misleading view and that the review writers appeared to have misunderstood important elements of trials.

Sativex, in the form of a mouth spray, contains the principal extracts - dronabinol and cannabidiol - found in the leaf and flower of the cannabis plant, and is the first cannabinoid preparation to be licensed for use in the treatment of muscle spasms in MS.

The review, in the December issue of Drug and Therapeutics Bulletin (DTB), published by BMJ Journals, says MS is estimated to affect around 60,000 people in England and Wales, and around one in every 1,000 people will develop the condition in the UK.

An increase in muscle tone, or spasticity, is a common symptom of the condition, causing involuntary spasms, immobility, disturbed sleep, and pain.

Complex combinations of drugs are sometimes needed to manage spasticity, but they do not work that well and have a range of unpleasant side-effects, the DTB says.

Sativex is intended for use as a second-line treatment in patients in whom these other options have failed. But the review said the trial data on which the success of Sativex is based are limited.

Overall, the trials, on which the drug's approval was based, did show a small difference in the numbers of patients in whom symptoms abated compared with those taking a dummy (placebo) preparation, it said.

But in many of these studies, Sativex was used for relatively short periods - from six weeks to four months. And none included an active ingredient with which the effects of Sativex could be compared.

Two of the trials included doses that exceeded the 12 daily sprays for which the preparation is licensed, it said, and one trial did not have sufficient numbers of participants to validate the results.

A third trial, which was properly designed, and did have sufficient numbers of participants, did not find any significant difference in symptom relief between those who took Sativex and those who did not, it said.

The preparation is also expensive, it added, and costs around 10 times as much as other drugs used for the secondary treatment of MS muscle spasms.

The review says the strength of the evidence is insufficient to warrant its routine use. "We believe that such limitations make it difficult to identify the place of this product in clinical practice," it concludes.

GW Pharmaceuticals, the drug's maker, said: "We are disappointed with the conclusions drawn and strongly believe these comments give a misleading view of the drug."

A spokesman said the drug had been licensed in the UK by the Medicines and Healthcare Products Regulatory Agency (MHRA) in 2010.

Dr Stephen Wright, the company's research and development director, said: "The writers appear to have misunderstood important elements of the design of Sativex clinical trials and provide a flawed assessment of Sativex data.

"Furthermore, the article contradicts the opinion of 22 separate national authorities in Europe and around the world that have granted approval for Sativex and recognise the important benefits it provides to MS patients with spasticity."

The company said the review "fails to focus on clinical trials data which form the basis for Sativex' approval and which guide its use in clinical practice."

A spokesman said: "The key Phase III data on Sativex is robust and compelling, showed highly statistically significant results for the primary and all key secondary endpoints, and is entirely consistent with the dosing recommended in the product label."

He said the DTB "significantly overstates the price of daily Sativex treatment", adding: "Follow-up of all patients prescribed Sativex in the UK, covering more than 12,000 patient years, shows that the average daily dose in long-term clinical use is four sprays per day, a daily cost of £5.50. This is half the cost assumed by the DTB."

Ed Holloway, head of care and services research at the MS Society, said: "The MHRA has already looked at the evidence surrounding Sativex and has decided it is a safe and effective treatment for spasticity - otherwise it would not have been licensed.

"The MS Society believes the MHRA is the right organisation to be making that decision and this latest paper does not provide any new evidence; it simply looks at the same evidence the MHRA has already reviewed via a rigorous process.

"As such, we do not believe this work should call into question the MHRA's decision. Sativex works for some people and we want everyone with MS to have all possible treatment options available to them to combat the symptoms of the condition."

PA

News
Young Winstone: His ‘tough-guy’ image is a misconception
people
Sport
Adnan Januzaj and Gareth Bale
footballManchester United set to loan out Januzaj to make room for Bale - if a move for the Welshman firms up
Arts and Entertainment
Ellie Levenson’s The Election book demystifies politics for children
bookNew children's book primes the next generation for politics
News
Outspoken: Alexander Fury, John Rentoul, Ellen E Jones and Katy Guest
newsFrom the Scottish referendum to the Ice Bucket Challenge, our writers voice their opinions
PROMOTED VIDEO
Life and Style
ebookNow available in paperback
ebooks
ebookPart of The Independent’s new eBook series The Great Composers
News
i100
Sport
Yaya Sanogo, Mats Hummels, Troy Deeney and Adnan Januzaj
footballMost Premier League sides are after a striker, but here's a full run down of the ins and outs that could happen over the next month
News
Nigel Farage celebrates with a pint after early local election results in the Hoy and Helmet pub in South Benfleet in Essex
peopleHe has shaped British politics 'for good or ill'
Arts and Entertainment
Pharrell Williams' “Happy” was the most searched-for song lyric of 2014
musicThe power of song never greater, according to our internet searches
Sport
Tim Sherwood raises his hand after the 1-0 victory over Stoke
footballFormer Tottenham boss leads list of candidates to replace Neil Warnock
Voices
Strictly Come Dancing was watched by 6.9m viewers
voicesIt has been hard to form generally accepted cultural standards since the middle of the 19th century – and the disintegration is only going to accelerate, says DJ Taylor
Arts and Entertainment
Roffey says: 'All of us carry shame and taboo around about our sexuality. But I was determined not to let shame stop me writing my memoir.'
books
News
Danielle George is both science professor and presenter
people
News
i100
News
Caplan says of Jacobs: 'She is a very collaborative director, and gives actors a lot of freedom. She makes things happen.'
people
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Selby Jennings: VP/SVP Credit Quant- NY- Investment Bank

    Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...

    Ashdown Group: Senior Marketing Executive- City of London, Old Street

    £40000 - £43000 per annum + benefits: Ashdown Group: Senior Marketing Executiv...

    Ashdown Group: Marketing Manager

    £40000 - £43000 per annum + benefits: Ashdown Group: An international organisa...

    Ashdown Group: Internal Recruiter -Rugby, Warwickshire

    £25000 - £30000 per annum: Ashdown Group: Internal Recruiter -Rugby, Warwicksh...

    Day In a Page

    War with Isis: The West needs more than a White Knight

    The West needs more than a White Knight

    Despite billions spent on weapons, the US has not been able to counter Isis's gruesome tactics, says Patrick Cockburn
    Return to Helmand: Private Davey Graham recalls the day he was shot by the Taliban

    'The day I was shot by the Taliban'

    Private Davey Graham was shot five times during an ambush in 2007 - it was the first, controversial photograph to show the dangers our soldiers faced in Helmand province
    Revealed: the best and worst airlines for delays

    Revealed: the best and worst airlines for delays

    Many flyers are failing to claim compensation to which they are entitled, a new survey has found
    The stories that defined 2014: From the Scottish independence referendum to the Ice Bucket Challenge, our writers voice their opinions

    The stories that defined 2014

    From the Scottish independence referendum to the Ice Bucket Challenge, our writers voice their opinions
    Stoke-on-Trent becomes first British city to be classified as 'disaster resilient' by the United Nations

    Disaster looming? Now you know where to head...

    Which British city has become the first to be awarded special 'resilience' status by the UN?
    Finally, a diet that works: Californian pastor's wildly popular Daniel Plan has seen his congregation greatly reduced

    Finally, a diet that works

    Californian pastor's wildly popular Daniel Plan has seen his congregation greatly reduced
    Say it with... lyrics: The power of song was never greater, according to our internet searches

    Say it with... lyrics

    The power of song was never greater, according to our internet searches
    Professor Danielle George: On a mission to bring back the art of 'thinkering'

    The joys of 'thinkering'

    Professor Danielle George on why we have to nurture tomorrow's scientists today
    Monique Roffey: The author on father figures, the nation's narcissism and New Year reflections

    Monique Roffey interview

    The author on father figures, the nation's narcissism and New Year reflections
    Introducing my anti-heroes of 2014

    Introducing my anti-heroes of 2014

    Their outrageousness and originality makes the world a bit more interesting, says Ellen E Jones
    DJ Taylor: Good taste? It's all a matter of timing...

    Good taste? It's all a matter of timing...

    It has been hard to form generally accepted cultural standards since the middle of the 19th century – and the disintegration is only going to accelerate, says DJ Taylor
    Olivia Jacobs & Ben Caplan: 'Ben thought the play was called 'Christian Love'. It was 'Christie in Love' - about a necrophiliac serial killer'

    How we met

    Olivia Jacobs and Ben Caplan
    Bill Granger recipes: Our chef's breakfasts will revitalise you in time for the New Year

    Bill Granger's healthy breakfasts

    Our chef's healthy recipes are perfect if you've overindulged during the festive season
    Transfer guide: From Arsenal to West Ham - what does your club need in the January transfer window?

    Who does your club need in the transfer window?

    Most Premier League sides are after a striker, but here's a full run down of the ins and outs that could happen over the next month
    The Last Word: From aliens at FA to yak’s milk in the Tour, here’s to 2015

    Michael Calvin's Last Word

    From aliens at FA to yak’s milk in the Tour, here’s to 2015